Literature DB >> 21171098

Evaluation of skeletal muscle during calf exercise by 31-phosphorus magnetic resonance spectroscopy in patients on statin medications.

Jim S Wu1, Catherine Buettner, Howard Smithline, Long H Ngo, Robert L Greenman.   

Abstract

Muscle pain is a common side effect of statin medications, but the cause is poorly understood. We characterized phosphocreatine (PCr) exercise recovery kinetics in 10 patients with hypercholesterolemia before and after a 4-week regimen of statin therapy using 31-phosphorus magnetic resonance spectroscopy ((31) P-MRS). (31) P spectra were obtained before, during, and after exercise on a calf flexion pedal ergometer. Creatine kinase (CK) serum levels were drawn before and after statin therapy. The mean metabolic recovery time constant in subjects increased from 28.1 s (SE = 6.5 s) to 55.4 s (SE = 7.4 s) after statin therapy. The unweighted mean of the pre/post-recovery time difference was -27.3 s (SE = 12.4 s; P = 0.02). Pre- and post-therapy CK levels were not significantly different (P = 0.50). Metabolic recovery time in the calf is prolonged in patients after statin use. This suggests that statins impair mitochondrial oxidative function, and (31) P MRS is a potential study model for statin-associated myopathy.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21171098      PMCID: PMC3332539          DOI: 10.1002/mus.21847

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  38 in total

Review 1.  Statin myopathies: pathophysiologic and clinical perspectives.

Authors:  S K Baker; M A Tarnopolsky
Journal:  Clin Invest Med       Date:  2001-10       Impact factor: 0.825

2.  Statin induced myopathy does not show up in MIBI scintigraphy.

Authors:  G Lupattelli; B Palumbo; H Sinzinger
Journal:  Nucl Med Commun       Date:  2001-05       Impact factor: 1.690

Review 3.  Safety of HMG-CoA reductase inhibitors: focus on atorvastatin.

Authors:  F Bernini; A Poli; R Paoletti
Journal:  Cardiovasc Drugs Ther       Date:  2001       Impact factor: 3.727

Review 4.  HMG-CoA reductase inhibitors and myotoxicity.

Authors:  M Ucar; T Mjörndal; R Dahlqvist
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

Review 5.  Severe rhabdomyolysis associated with the cerivastin-gemfibrozil combination therapy: report of a case.

Authors:  T K Lau; D R Leachman; R Lufschanowski
Journal:  Tex Heart Inst J       Date:  2001

6.  The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity.

Authors:  Jun-ichi Hanai; Peirang Cao; Preeti Tanksale; Shintaro Imamura; Eriko Koshimizu; Jinghui Zhao; Shuji Kishi; Michiaki Yamashita; Paul S Phillips; Vikas P Sukhatme; Stewart H Lecker
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 7.  Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?

Authors:  Marc Evans; Alan Rees
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

8.  Statin-associated myopathy with normal creatine kinase levels.

Authors:  Paul S Phillips; Richard H Haas; Sergei Bannykh; Stephanie Hathaway; Nancy L Gray; Bruce J Kimura; Georgirene D Vladutiu; John D F England
Journal:  Ann Intern Med       Date:  2002-10-01       Impact factor: 25.391

9.  Association between statin-associated myopathy and skeletal muscle damage.

Authors:  Markus G Mohaupt; Richard H Karas; Eduard B Babiychuk; Verónica Sanchez-Freire; Katia Monastyrskaya; Lakshmanan Iyer; Hans Hoppeler; Fabio Breil; Annette Draeger
Journal:  CMAJ       Date:  2009-07-07       Impact factor: 8.262

10.  Large-scale chemical dissection of mitochondrial function.

Authors:  Bridget K Wagner; Toshimori Kitami; Tamara J Gilbert; David Peck; Arvind Ramanathan; Stuart L Schreiber; Todd R Golub; Vamsi K Mootha
Journal:  Nat Biotechnol       Date:  2008-02-24       Impact factor: 54.908

View more
  18 in total

1.  Statins and Exercise Training Response in Heart Failure Patients: Insights From HF-ACTION.

Authors:  Jacob P Kelly; Allison Dunning; Phillip J Schulte; Mona Fiuzat; Eric S Leifer; Jerome L Fleg; Lawton S Cooper; Steven J Keteyian; Dalane W Kitzman; Ileana L Pina; William E Kraus; David J Whellan; Christopher M O'Connor; Robert J Mentz
Journal:  JACC Heart Fail       Date:  2016-07-06       Impact factor: 12.035

2.  Evidence for metabolic aberrations in asymptomatic persons with type 2 diabetes after initiation of simvastatin therapy.

Authors:  Manish Suneja; Daniel K Fox; Brian D Fink; Judy A Herlein; Christopher M Adams; William I Sivitz
Journal:  Transl Res       Date:  2015-01-28       Impact factor: 7.012

3.  Simvastatin impairs exercise training adaptations.

Authors:  Catherine R Mikus; Leryn J Boyle; Sarah J Borengasser; Douglas J Oberlin; Scott P Naples; Justin Fletcher; Grace M Meers; Meghan Ruebel; M Harold Laughlin; Kevin C Dellsperger; Paul J Fadel; John P Thyfault
Journal:  J Am Coll Cardiol       Date:  2013-04-10       Impact factor: 24.094

Review 4.  Exercise training in chronic heart failure: improving skeletal muscle O2 transport and utilization.

Authors:  Daniel M Hirai; Timothy I Musch; David C Poole
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-28       Impact factor: 4.733

5.  MRI in Lower Extremity Peripheral Arterial Disease: Recent Advancements.

Authors:  Amy W Pollak; Christopher M Kramer
Journal:  Curr Cardiovasc Imaging Rep       Date:  2013-02-01

Review 6.  Effect of statins on skeletal muscle: exercise, myopathy, and muscle outcomes.

Authors:  Beth A Parker; Paul D Thompson
Journal:  Exerc Sport Sci Rev       Date:  2012-10       Impact factor: 6.230

7.  Effects of Coenzyme Q10 on Skeletal Muscle Oxidative Metabolism in Statin Users Assessed Using 31P Magnetic Resonance Spectroscopy: a Randomized Controlled Study.

Authors:  Catherine Buettner; Robert L Greenman; Long H Ngo; Jim S Wu
Journal:  J Nat Sci       Date:  2016

8.  Statins and physical activity in older men: the osteoporotic fractures in men study.

Authors:  David S H Lee; Sheila Markwardt; Leah Goeres; Christine G Lee; Elizabeth Eckstrom; Craig Williams; Rongwei Fu; Eric Orwoll; Peggy M Cawthon; Marcia L Stefanick; Dawn Mackey; Douglas C Bauer; Carrie M Nielson
Journal:  JAMA Intern Med       Date:  2014-08       Impact factor: 21.873

Review 9.  Statin-Associated Muscle Disease: Advances in Diagnosis and Management.

Authors:  Beth A Taylor; Paul D Thompson
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

10.  Effect of statins on skeletal muscle function.

Authors:  Beth A Parker; Jeffrey A Capizzi; Adam S Grimaldi; Priscilla M Clarkson; Stephanie M Cole; Justin Keadle; Stuart Chipkin; Linda S Pescatello; Kathleen Simpson; C Michael White; Paul D Thompson
Journal:  Circulation       Date:  2012-11-26       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.